UCLA Journal of Radiation Oncology APRIL 2022 - Flipbook - Page 35
UCLA RADIATION ONCOLOGY JOURNAL
AWARDS, PUBLICATIONS,
AND GRANTS
Recent wins from the UCLA Department of Radiation Oncology
Eric Morris, PhD (PGY-2) won the 2022
ViewRay Plan challenge for SBRT Liver.
Amar Kishan, M.D. led the publication
of the first report from an international
consortium of prostate cancer clinical
trial groups (the MARCAP consortium),
published in Lancet Oncology, that first
the time quantified the benefit of adding/
prolonging hormone therapy in the
treatment of prostate cancer
Joanne B. Weidhaas, MD, PhD, MSM,
was a first author on a publication
entitled, Germline biomarkers predict
toxicity to anti-PD1/PDL1 checkpoint
therapy ,published in the Journal for
ImmunoTherapy of Cancer / BMJ Journals.
Ke Sheng, PhD, DABR, FAAPM, was
recently awarded an NIH grant: NIH SBIR
Phase IIB, R44CA183390-05 (Yonemoto,
Sheng), Bringing 4π radiation therapy to
the clinic 4/1/2022-3/30/2026 $4,000,000
(total). Dr. Sheng will serve as the PI in
concert with Dr. Minsong Cao and Dr.
Drew Moghanaki, who serve as co-Is on
the grant.
Martin Ma, MD, PhD (PGY-4) recently
received a Best Abstract Award at The
Radiation Oncology Summit from the
American College of Radiation Oncology.
James Lamb, PhD and his students have
three new publications:
Offline generator for digitally
reconstructed radiographs of a
commercial stereoscopic radiotherapy
image‐guidance system, published in the
Journal of Applied Clinical Medical Physics
Machine‐assisted interpolation algorithm
for semi‐automated segmentation of highly
deformable organs, published in Medical
Physics.
Barriers and facilitators to clinical
implementation of radiotherapy treatment
planning automation: a survey study
of medical dosimetrists, published in
the Journal of Applied Clinical Medical
Physics .
Martin Ma, MD, PhD (PGY-4) was recently
awarded a Novocure Travel Grant at The
Radiation Oncology Summit from the
American College of Radiation Oncology.
Amar Kishan, M.D., was awarded a $1.15
million grant from the Department of
Defense for multi-disciplinary study of
prostate cancer.
Ricky R. Savjani, MD, PhD (PGY-4)
recently received a Google Cloud Research
Innovator Award.
Amar Kishan, M.D. led the publication
of a large, multi-institutional study that
incorporated clinical trial data to evaluate
the optimal duration of hormone therapy
with high dose radiation, published in
JAMA Oncology.
Martin Ma, MD, PhD (PGY-4) had two
recent publications:
A Prospective Phase II Study of Automated
Non-Coplanar VMAT for Recurrent
Head and Neck Cancer: Initial Report of
Feasibility, Safety, and Patient-Reported
Outcomes, published in Cancers. **Dr. Ma
was a Co-First Author on this publication.
Androgen deprivation therapy use and
duration with definitive radiotherapy for
localised prostate cancer: an individual
patient data meta-analysis, in Lancet
Oncology.
35